Robert Montal

Statistics

Publications

Citations

1.2K

H-Index

Active since

2016

Affiliations

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer(Current)

Institució Catalana de Recerca i Estudis Avançats

Icahn School of Medicine at Mount Sinai

Universitat de Barcelona

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas

Robert Montal is an author at Consorci Institut D'Investigacions Biomediques August Pi I Sunyer specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

MedicineOncologyPathologyRadiation OncologyHepatologyBiliary CancersEngineeringBiostatisticsTumor BiologyCancer Therapy

Publications per year

2016–2024

Publications

Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial

Roser Pinyol, Robert Montal, Laia Bassaganyas et al. · Gut · 2018 · 323 citations · Full text

Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma

Robert Montal, Daniela Sia, Carla Montironi et al. · Journal of Hepatology · 2020 · 274 citations · Full text

Tumor Biology, Hepatology, Medicine +8

Objective response by mRECIST as a predictor and potential surrogate end-point of overall survival in advanced HCC

Riccardo Lencioni, Robert Montal, Ferràn Torres et al. · Journal of Hepatology · 2017 · 224 citations · Full text

Prognostic Evaluation, Oncology, Potential Surrogate End-point +6

Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity

Agrin Moeini, Daniela Sia, Zhongyang Zhang et al. · Journal of Hepatology · 2017 · 168 citations

Hepatology, Biliary Tract, Biliary Cancer +9

Molecular portrait of high alpha-fetoprotein in hepatocellular carcinoma: implications for biomarker-driven clinical trials

Robert Montal, Carmen Andreu-Oller, Laia Bassaganyas et al. · British Journal of Cancer · 2019 · 90 citations · Full text

1–5 of 10